Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracameral Steroids for Corneal Edema in Phacoemulsification
NCT05271058Phase 3Completed
- Sponsor
- Cairo University
- Start
- Jun 2019
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexamethasone and triamcinolone in corneal edema (3 arms), sponsored by Cairo University. Primary endpoints: Corneal edema at 1 day, Central corneal thickness at 3 months and 1 more. Started Jun 2019; status: completed.
02
Drugs
dexamethasonetriamcinolone
03
Conditions
corneal edema
Beyond the preview
Go deeper on NCT05271058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05271058.